Pfizer and Washington University Announce a Groundbreaking Collaboration

Pfizer and Washington University Announce a Groundbreaking Collaboration

NEW YORK, N.Y., May 17 - In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds. Under the five-year agreement announced today, Pfizer will provide $22.5 million to Washington University and give its scientists access to research data on a large array of Pfizer pharmaceutical candidates that are currently or were formerly in clinical testing.

You can read the full press release here (PDF).